7-Bromo-4-methyl-3,4-dihydro-2H-1,4-benzoxazine; 10g; F.W. 228.09; C9H10BrNO; CAS: (154264-95-6)
-
P/N:
CC13510EA
- UOM: EA
- UOM Qty: 1
|
|
4-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,4-benzoxazine; 250mg; C15H22BNO3; CAS: (519054-54-7)
-
P/N:
CC13539CB
- UOM: EA
- UOM Qty: 1
|
|
4-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,4-benzoxazine; 1g; C15H22BNO3; CAS: (519054-54-7)
-
P/N:
CC13539DA
- UOM: EA
- UOM Qty: 1
|
|
2-(3-Pyridyl)-1,3-thiazole-4-carboxylic acid, 97%; 250mg; F.W. 206; C9H6N2O2S; CAS: (39067-29-3)
-
P/N:
CC13701CB
- UOM: EA
- UOM Qty: 1
|
|
2-(3-Pyridyl)-1,3-thiazole-4-carboxylic acid, 97%; 1g; F.W. 206; C9H6N2O2S; CAS: (39067-29-3)
-
P/N:
CC13701DA
- UOM: EA
- UOM Qty: 1
|
|
5-(2-Methyl-1,3-thiazol-4-yl)-3-isoxazolecarboxylic acid, 97%; 250mg; F.W. 210.21; C8H6N2O3S; CAS: (368870-05-7)
-
P/N:
CC14001CB
- UOM: EA
- UOM Qty: 1
|
|
5-(2-Methyl-1,3-thiazol-4-yl)-3-isoxazolecarboxylic acid, 97%; 1g; F.W. 210.21; C8H6N2O3S; CAS: (368870-05-7)
-
P/N:
CC14001DA
- UOM: EA
- UOM Qty: 1
|
|
4-(1,3-Oxazol-5-yl)benzoic acid, 97%; 250mg; F.W. 189.17; C10H7NO3; CAS: (250161-45-6)
-
P/N:
CC14501CB
- UOM: EA
- UOM Qty: 1
|
|
4-(1,3-Oxazol-5-yl)benzoic acid, 97%; 1g; F.W. 189.17; C10H7NO3; CAS: (250161-45-6)
-
P/N:
CC14501DA
- UOM: EA
- UOM Qty: 1
|
|
2,2'-Bithiophene-5-carboxylic acid, 97%; 1g; F.W. 210.28; C9H6O2S2; CAS: (2060-55-1)
-
P/N:
CC14601DA
- UOM: EA
- UOM Qty: 1
|
|
